Zitong Feng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Zitong Feng has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Brent A. Bauer
Division of General Internal Medicine, Mayo Clinic, Rochester, MN, USA
2 shared publications - Huijun Yang
Key Laboratory of Birth Regulation and Control Technology of National Health Commission of China, Shandong Provincial Maternal and Child Health Care Hospital, Jinan, China
2 shared publications - Juan Yang
Division of General Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA
2 shared publications - Manisha Salinas
Department of Hematology and Oncology, Mayo Clinic, Jacksonville, FL, USA
2 shared publications - Mingzhu Xu
Department of Rehabilitation Medicine, Shenzhen Hospital, Southern Medical University, Shenzhen, 518100, China
2 shared publications - Molly J. Mallory
Division of General Internal Medicine, Mayo Clinic, Rochester, MN, USA
2 shared publications
Latest Publications
- 1 August 2021
- Published by Elsevier in Clinical Nutrition ESPEN
- Vol. 44, 50-60
Dietary supplements and herbal medicine for COVID-19: A systematic review of randomized control trials
- 1 August 2021
- Published by Elsevier in Clinical Nutrition ESPEN
- Vol. 44, 50-60
Dietary supplements and herbal medicine for COVID-19: A systematic review of randomized control trials
- RetractedOpen Access
- 1 January 2021
- Published by Wiley in BioMed Research International
- Vol. 2021 (1)
[Retracted] Effects of Tai Chi on Patients with Mild Cognitive Impairment: A Systematic Review and Meta‐analysis of Randomized Controlled Trials
Background and Purpose. Mild cognitive impairment (MCI) is a common condition, which threatens the quality of life of older adults. Tai Chi (TC) is growing in popularity among patients with MCI. This study is aimed at evaluating the effectiveness and safety of TC in older adults with MCI. Design. Randomized controlled trials (RCTs) from multiple databases from inception to December 2020 published in English were searched. Two researchers independently performed eligible study screening and data extraction. The methodological quality was assessed with the Jadad score. Meta‐analysis of RCTs on TC in the treatment of MCI was performed with RevMan Version 5.4.1. Results. Seven RCTs with 1265 participants were included. For most RCTs, the overall reporting of methodological quality was high. Results of the meta‐analysis indicate that TC improved MCI patients’ cognitive function significantly, including overall cognitive function (MD = −2.24, 95% CI ‐3.51 to ‐0.97, P = 0.0005), memory and learning (SMD = 0.83, 95% CI 0.22 to 1.45, P = 0.008), visuospatial ability (MD = 3.15, 95% CI 0.74 to 5.56, P = 0.01), executive functions (MD = 0.32, 95% CI 0.03 to 0.61, P = 0.03), and physical activity (MD = 18.78, 95% CI 10.80 to 26.76, P < 0.00001). However, no significant benefit was found for TC on psychological activity (MD = 0.17, 95% CI ‐0.62 to 0.96, P = 0.36) and biomarker improvement. Conclusion. The meta‐analysis confirmed the clinical therapeutic effect of TC for MCI. More rigorous and long‐term follow‐up RCTs should be conducted in the future.
- 1 January 2021
- Published by Wiley in BioMed Research International
- Vol. 2021 (1)
RetractedOpen Access[Retracted] Effects of Tai Chi on Patients with Mild Cognitive Impairment: A Systematic Review and Meta‐analysis of Randomized Controlled Trials
Background and Purpose. Mild cognitive impairment (MCI) is a common condition, which threatens the quality of life of older adults. Tai Chi (TC) is growing in popularity among patients with MCI. This study is aimed at evaluating the effectiveness and safety of TC in older adults with MCI. Design. Randomized controlled trials (RCTs) from multiple databases from inception to December 2020 published in English were searched. Two researchers independently performed eligible study screening and data extraction. The methodological quality was assessed with the Jadad score. Meta‐analysis of RCTs on TC in the treatment of MCI was performed with RevMan Version 5.4.1. Results. Seven RCTs with 1265 participants were included. For most RCTs, the overall reporting of methodological quality was high. Results of the meta‐analysis indicate that TC improved MCI patients’ cognitive function significantly, including overall cognitive function (MD = −2.24, 95% CI ‐3.51 to ‐0.97, P = 0.0005), memory and learning (SMD = 0.83, 95% CI 0.22 to 1.45, P = 0.008), visuospatial ability (MD = 3.15, 95% CI 0.74 to 5.56, P = 0.01), executive functions (MD = 0.32, 95% CI 0.03 to 0.61, P = 0.03), and physical activity (MD = 18.78, 95% CI 10.80 to 26.76, P < 0.00001). However, no significant benefit was found for TC on psychological activity (MD = 0.17, 95% CI ‐0.62 to 0.96, P = 0.36) and biomarker improvement. Conclusion. The meta‐analysis confirmed the clinical therapeutic effect of TC for MCI. More rigorous and long‐term follow‐up RCTs should be conducted in the future.
- Open Access
- 14 August 2019
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2019, 1-13
The Effectiveness and Safety of Acupoint Catgut Embedding for the Treatment of Postmenopausal Osteoporosis: A Systematic Review and Meta-Analysis
Purpose. To evaluate the effectiveness and safety of acupoint catgut embedding therapy (ACET) in postmenopausal osteoporosis (PMOP). Methods. Review of some databases from their inception to June 2018 and randomized controlled trials (RCTs) in which ACET with PMOP were included. Two researchers extracted and evaluated the information independently. Cochrane Collaboration’s tool and Jadad scale were used to evaluate the quality of the studies. RevMan V.5.3.3 software was used to carry out the meta-analysis while trial sequential analysis (TSA) performed with TSA 0.9 software. Results. 12 RCTs with 876 participants were included in this review. Meta-analysis showed that ACET alone was not superior to medication in effectiveness rate (RR= 1.11; 95% CI (0.89, 1.40); P=0.35) and E2 (SMD= 0.20; 95% CI (-0.17, 0.57); P=0.28; I2=20%) while ACET combining medication was more effective on the effectiveness rate (RR= 1.32; 95% CI (1.20, 1.46); P<0.000 01) and E2 (SMD= 1.24; 95% CI (0.63, 1.84); P<0.0001). Additionally, ACET combining calcium could increase the bone mineral density (BMD) of the L2~4 vertebrae and femur-neck [ = 0.03; 95% CI (0.01, 0.05); P=0.003; and = 0.07; 95% CI (0.03, 0.10); P = 0.0006], reduce TCM syndrome score [WMD = -1.85; 95% CI (-2.13, -1.57); P<0.000 01], improve patient’s quality of life [ = 6.90; 95% CI (3.90, 9.89); P<0.000 01; and = 12.34; 95% CI (5.09, 19.60); P=0.0009], and relieve pain [ = -1.26; 95% CI (-1.66, -0.85); P<0.000 01; and = -2.59; 95% CI (-4.76, -0.43); P= 0.02]. The TSA showed that the effectiveness of ACET for PMOP was demonstrated accurately. Conclusions. ACET combining medication but not ACET alone is more effective than medication as comparison in the treatment of PMOP. As a novel treatment, ACET shows the potential of effectiveness and deserves further high quality of well-designed study.- 14 August 2019
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2019, 1-13
Open AccessThe Effectiveness and Safety of Acupoint Catgut Embedding for the Treatment of Postmenopausal Osteoporosis: A Systematic Review and Meta-Analysis
Purpose. To evaluate the effectiveness and safety of acupoint catgut embedding therapy (ACET) in postmenopausal osteoporosis (PMOP). Methods. Review of some databases from their inception to June 2018 and randomized controlled trials (RCTs) in which ACET with PMOP were included. Two researchers extracted and evaluated the information independently. Cochrane Collaboration’s tool and Jadad scale were used to evaluate the quality of the studies. RevMan V.5.3.3 software was used to carry out the meta-analysis while trial sequential analysis (TSA) performed with TSA 0.9 software. Results. 12 RCTs with 876 participants were included in this review. Meta-analysis showed that ACET alone was not superior to medication in effectiveness rate (RR= 1.11; 95% CI (0.89, 1.40); P=0.35) and E2 (SMD= 0.20; 95% CI (-0.17, 0.57); P=0.28; I2=20%) while ACET combining medication was more effective on the effectiveness rate (RR= 1.32; 95% CI (1.20, 1.46); P<0.000 01) and E2 (SMD= 1.24; 95% CI (0.63, 1.84); P<0.0001). Additionally, ACET combining calcium could increase the bone mineral density (BMD) of the L2~4 vertebrae and femur-neck [ = 0.03; 95% CI (0.01, 0.05); P=0.003; and = 0.07; 95% CI (0.03, 0.10); P = 0.0006], reduce TCM syndrome score [WMD = -1.85; 95% CI (-2.13, -1.57); P<0.000 01], improve patient’s quality of life [ = 6.90; 95% CI (3.90, 9.89); P<0.000 01; and = 12.34; 95% CI (5.09, 19.60); P=0.0009], and relieve pain [ = -1.26; 95% CI (-1.66, -0.85); P<0.000 01; and = -2.59; 95% CI (-4.76, -0.43); P= 0.02]. The TSA showed that the effectiveness of ACET for PMOP was demonstrated accurately. Conclusions. ACET combining medication but not ACET alone is more effective than medication as comparison in the treatment of PMOP. As a novel treatment, ACET shows the potential of effectiveness and deserves further high quality of well-designed study.